GlaxoSmithKline | GSK - DEBITO

Prezzo Delle Azioni
1,913.50
Cambio Giornaliero
-15.00 -0.78%
Mensile
-10.75%
Annuale
32.10%
Q2 Previsione
1,986.06




DEBITO Cambiamento Data
AbbVie USD 67.5B 67.5B 2025-12
Alcon AG USD 509M 4.74B 2025-12
Almirall EUR 342.86M 61.94M 2025-12
Amgen USD 54.6B 17M 2025-12
argenx SE USD 43.15M 4.1M 2025-06
AstraZeneca USD 33.92B 4.3B 2026-03
Bayer EUR 39.39B 1.31B 2025-03
Biogen USD 6.56B 275.1M 2026-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Eli Lilly USD 42.5B 3.6M 2025-12
Fresenius EUR 12.85B 778M 2025-06
Fresenius Medical Care EUR 10.8B 322.94M 2025-12
Galapagos EUR 7.5M 3.36M 2025-09
Genmab DKK 148M 5M 2025-06
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Glaxosmithkline GBP 17.75B 396M 2025-09
GRIFOLS EUR 9.57B 746.56M 2025-12
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Lonza CHF 4.71B 915M 2024-12
Merck EUR 12.1B 2.7B 2025-09
Merck USD 49.34B 7.97B 2025-12
Novartis USD 35.38B 2.74B 2025-12
Novo Nordisk DKK 118.72B 61.75B 2025-03
Orion EUR 305.4M 15.8M 2025-12
Pfizer USD 60.85B 78M 2025-09
Philips EUR 8.38B 41M 2025-09
Recordati EUR 2.5B 33.23M 2025-09
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 20.33B 1.43B 2025-12
Smith & Nephew USD 3.32B 334M 2024-12
UCB EUR 3.03B 12M 2024-12